Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 14 |
---|
Ligand | BDBM50235907 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_462870 (CHEMBL928788) |
---|
IC50 | 3.3±n/a nM |
---|
Citation | Liu, C; Lin, J; Pitt, S; Zhang, RF; Sack, JS; Kiefer, SE; Kish, K; Doweyko, AM; Zhang, H; Marathe, PH; Trzaskos, J; Mckinnon, M; Dodd, JH; Barrish, JC; Schieven, GL; Leftheris, K Benzothiazole based inhibitors of p38alpha MAP kinase. Bioorg Med Chem Lett18:1874-9 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 14 |
---|
Name: | Mitogen-activated protein kinase 14 |
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 41286.76 |
Organism: | Homo sapiens (Human) |
Description: | Q16539 |
Residue: | 360 |
Sequence: | MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ
SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ
KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG
TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA
QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
|
|
|
BDBM50235907 |
---|
n/a |
---|
Name | BDBM50235907 |
Synonyms: | 6-(4-(2-fluorophenyl)-1H-imidazol-5-yl)-N-isopropylbenzo[d]thiazol-2-amine | CHEMBL403942 |
Type | Small organic molecule |
Emp. Form. | C19H17FN4S |
Mol. Mass. | 352.428 |
SMILES | CC(C)Nc1nc2ccc(cc2s1)-c1[nH]cnc1-c1ccccc1F |
Structure |
|